Chemoinformaics analysis of Methyl alpha-D-galactopyranoside
| Molecular Weight | 194.183 | nRot | 2 |
| Heavy Atom Molecular Weight | 180.071 | nRig | 6 |
| Exact Molecular Weight | 194.079 | nRing | 1 |
| Solubility: LogS | -0.07 | nHRing | 1 |
| Solubility: LogP | -2.139 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 25.8371 |
| nHD | 4 | BPOL | 17.5169 |
| QED | 0.386 |
| Synth | 3.505 |
| Natural Product Likeliness | 2.574 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.076 |
| HIA | 0.876 |
| CACO-2 | -5.262 |
| MDCK | 0.000805272 |
| BBB | 0.467 |
| PPB | 0.122474 |
| VDSS | 0.471 |
| FU | 0.818249 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.075 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.439 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.087 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.142 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.021 |
| CL | 1.614 |
| T12 | 0.61 |
| hERG | 0.028 |
| Ames | 0.344 |
| ROA | 0.136 |
| SkinSen | 0.046 |
| Carcinogencity | 0.024 |
| EI | 0.036 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.889347 |